TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Health In Tech, Inc. Class A ( (HIT) ) has shared an announcement.
On December 2, 2025, Health In Tech announced that its executive management team, vice presidents, and Board of Directors have voluntarily extended the lock-up restrictions on their shares for an additional six months, until June 20, 2026. This decision, following the company’s IPO in December 2024, reflects the leadership’s confidence in the company’s growth prospects and ongoing initiatives in technology and market expansion.
The most recent analyst rating on (HIT) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.
Spark’s Take on HIT Stock
According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.
Health In Tech, Inc. shows strong financial performance and positive earnings call sentiment, which are the primary drivers of its score. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates overvaluation, which dampens the overall score.
To see Spark’s full report on HIT stock, click here.
More about Health In Tech, Inc. Class A
Health In Tech (Nasdaq: HIT) is an Insurtech platform company that leverages third-party AI technology to enhance the healthcare industry by streamlining processes through vertical integration, process simplification, and automation. The company aims to improve the underwriting, sales, and service processes for insurance companies, licensed brokers, and TPAs.
Average Trading Volume: 395,304
Technical Sentiment Signal: Strong Sell
Current Market Cap: $92.76M
See more insights into HIT stock on TipRanks’ Stock Analysis page.